Cytokines and Immune Regulation in Thyroid Autoimmunity

References

• Weetman AP, McGregor AM. Autoimmune thyroid disease: developments in our understanding. Endoc Rev 1984; 5: 309–355
   PubMed Web of Science ®Google Scholar
• Burman KD, Baker K. Immune mechanism in Graves' disease. Endoc Rev 1985; 6: 183–232
   PubMed Web of Science ®Google Scholar
• McLachlan SM, Pegg CAS, Atherton MC, Middleton SL, Dickinson A, Clark F. Subpopulations of thyroid autoantibody secreting lymphocytes in Graves' and Hashimoto thyroid glands. Clin Exp Immunol 1986; 65: 319–328
   PubMed Web of Science ®Google Scholar
• Ueki Y, Eguchi K, Otsubo T, Kawabe Y, Shimomura C, Tezuka H. Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease. J. Clin Endocrinol Metab 1989; 69: 939–945
   PubMedGoogle Scholar
• Margolick JB, Hsu SM, Volkman DJ, Burman KD, Fauci AS. Immunohistochemical characterization of intrathyroid lymphocytes in Graves' disease. Am J Med 1984; 76: 815–821
   PubMed Web of Science ®Google Scholar
• Margolick JB, Weetman AP, Burman KD. Immunohistochemical analysis of intrathyroid lymphocytes in Graves' disease: evidence of activated T cells and production of interferon-r. Clin Immunol Immunopathol 1988; 47: 208–218
   PubMedGoogle Scholar
• Issekutz TB. Effects of six different cytokines on lymphocyte adherence to microvascular endothelium and in vivo lymphocyte migration in the rat. J. Immunol 1990; 144: 2140–2146
   PubMed Web of Science ®Google Scholar
• Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425–434
   PubMed Web of Science ®Google Scholar
• Lucas-Martin A, Foz-Sala M, Todd I, Bottazzo GF, Pujol Borrell. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid disease: relationship with lymphocytic infiltration and thyroid autoantibodies. J Clin Endocrinol Metab 1988; 66: 367–375
   PubMed Web of Science ®Google Scholar
• Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RCG, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease. Lancet 1983; ii: 1111–1115
   Google Scholar
• Basham TY, Merigan TC. Recombinant interferon-r increases HLA-DR synthesis and expression. J Immunol 1983; 130: 1492–1497
   PubMed Web of Science ®Google Scholar
• Czernielewski JM, Bagot M. Class II MHC antigen expression by human keratinocytes results from lymph-epidermal interaction and T-interferon production. Clin Exp Immunol 1986; 66: 295–302
   PubMedGoogle Scholar
• Weetman AP, Rees AJ. Synergistic effects of recombinant tumor necrosis factor and interferon-gamma on rat thyroid cell growth and la antigen expression. Immunology 1988; 63: 285–289
   PubMedGoogle Scholar
• Matsunaga M, Eguchi K, Fukuda T, Kurata A, Tezuka H., Shimomura C. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease. J Clin Endocrinol Metab 1986; 62: 723–728
   PubMed Web of Science ®Google Scholar
• Todd I, Pujol-Borrell R, Hammond J, Bottazzo GF, Feldman M. Interferon-r induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 1985; 61: 265–273
   PubMed Web of Science ®Google Scholar
• Hamilton F, Black M, Farquharson MA, Stewart C, Foulis AK. Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon-gamma-containing lymphocytes in human thyroid autoimmune disease. Clin Exp Immunol 1991; 83: 64–68
   PubMed Web of Science ®Google Scholar
• Migita K, Eguchi K, Otsubo T, Kawakami A, Nakao H, Ueki Y. Cytokine regulation of HLA on thyroid epithelial cells. Clin Exp Immunol 1990; 82: 548–552
   PubMed Web of Science ®Google Scholar
• Miossec P, Cavender P, Ziff M. Production of interleukin 1 by human endothelial cells. J Immunol 1986; 136: 2486–2491
   PubMed Web of Science ®Google Scholar
• Grubeck-Loebenstein B, Buchan G, Chantry D, Kassal H, Londei M, Pirich K. Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 α and interleukin-6. Clin Exp Immunol 1989; 77: 324–330
   PubMed Web of Science ®Google Scholar
• Zheng RQH, Abney E, Chu CQ, Field B, Grubeck-Loebenstein B, Maini RN. Detection of interleukin-6 and interleukin-1 production in human thyroid epithelial cells by non-radioactive in situ hybridization and immunohistochemical methods. Clin Exp Immunol 1991; 83: 314–319
   PubMedGoogle Scholar
• Kawabe Y, Eguchi K, Shimomura C, Mine M, Otsubo T, Ueki Y. Interleukin-1 production and action in thyroid tissue. J Clin Endocrinol Metab 1989; 68: 1174–1183
   PubMed Web of Science ®Google Scholar
• Wall JR, Baur R, Schleusenser H, Bandy-Defoe P. Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies. J. Clin Endocrinol Metab 1983; 56: 164–169
   PubMed Web of Science ®Google Scholar
• Jansson R., Totterman TH, Sallstorm J, Dahlberg PA. Thyroid-infiltrating T lymphocyte subsets in Hashimoto's thyroiditis. J. Clin Endocrinol Metab 1983; 56: 1164–1168
   PubMed Web of Science ®Google Scholar
• Bene MC, Derennes V, Faure G, Thomas JL, Duheile J, Leclere J. Graves' disease: in situ localization of lymphoid T cell sub-populations. Clin Exp Immunol 1983; 52: 311–316
   PubMed Web of Science ®Google Scholar
• Warford A, McLachlan SM, Malcolm AJ, Young ET, Farndon JR, Smith BR. Characterization of lymphoid cells in thyroid of patients with Graves' disease. Clin Exp Immunol 1984; 57: 626–632
   PubMedGoogle Scholar
• Jansson R, Karlsson A, Forsum U. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Clin Exp Immunol 1984; 58: 264–272
   PubMed Web of Science ®Google Scholar
• Jansson R, Tötterman TH, Sallostorm J, Dahlberg PA. Intrathyroidal and circulating lymphocyte subsets in different stages of autoimmune post-partum thyroiditis. J Clin Endocrinol Metab 1984; 58: 942–946
   PubMed Web of Science ®Google Scholar
• Misaki T, Konishi J, Nakashima T, Iida Y, Kasagi K, Endo K. Immunohistological phenotyping of thyroid infiltrating lymphocytes in Graves' disease and Hashimoto's thyroiditis. Clin Exp Immunol 1985; 60: 104–110
   PubMedGoogle Scholar
• Ishikawa N, Eguchi K, Otsubo T, Ueki Y, Fukuda T, Tezuka H. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease. J. Clin Endocrinol Metab 1987; 65: 17–23
   PubMed Web of Science ®Google Scholar
• Ueki Y, Eguchi K, Otsubo T, Kawabe Y, Shimomura C, Matsu-Naga M. Phenotypic analysis and concanavalin-A-induced suppressor cell dysfunction of intrathyroidal lymphocytes from patients with Graves' disease. J Clin Endocrinol Metab 1988; 67: 1018–1024
   PubMed Web of Science ®Google Scholar
• Morimoto C, Letvin NL, Distaso JA, Aldrich WR, Schlossman SF. The isolation and characterization of the human suppressor-inducer T cell subset. J. Immunol 1985; 134: 1508–1515
   PubMed Web of Science ®Google Scholar
• Morimoto C, Letvin NL, Boyd AW, Hagen M, Brown HM, Kornacki MM. The isolation and characterization of the human helper-inducer T cell subset. J. Immunol 1985; 134: 3762–3769
   PubMed Web of Science ®Google Scholar
• Clement LT, Yamashita N, Martin AM. The functionally distinct subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation dependent post-thymic differentiation. J Immunol 1988; 141: 1464–1470
   PubMed Web of Science ®Google Scholar
• Eguchi K, Ueki Y, Shimomura C, Otsubo T, Nakao H, Migita K. Increment in the Tal+ cells in the peripheral blood and thyroid tissue of patients with Graves' disease. J Immunol 1989; 142: 4233–4240
   PubMedGoogle Scholar
• Tezuka H, Eguchi K, Fukuda T, Otsubo T, Kawabe Y, Ueki Y. Natural killer like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease. J Clin Endocrinol Metab 1988; 66: 702–707
   PubMed Web of Science ®Google Scholar
• Ueki Y, Eguchi K, Fukuda T, Otsubo T, Kawabe Y, Shimomura C. Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease. J Clin Endocrinol Metab 1987; 65: 922–928
   PubMedGoogle Scholar
• Ueki Y, Eguchi K, Otsubo T, Kawabe Y, Shimomura C, Tezuka H. Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease. J Clin Endocrinol Metab 1989; 69: 939–945
   PubMedGoogle Scholar
• Stamper HB, Woodruff JJ. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculatory lymphocytes for high-endothelial venules. J Exp Med 1976; 144: 828–833
   PubMed Web of Science ®Google Scholar
• Kabel PJ, Voorbij HAM, De Haan-Meulman M, Pals ST, Drexhage HA. High endothelial venules present in lymphoid cell accumulations in thyroid affected by autoimmune disease: a study in men and BB rats of functional activity and development. J Clin Endocrinol Metab 1989; 68: 744–751
   PubMed Web of Science ®Google Scholar
• Pals ST, Horst E, Scheper RJ, Meijer CJLM. Mechanism of human lymphocyte migration and their role in the pathogenesis of disease. Immunol Rev 1989; 108: 111–133
   PubMed Web of Science ®Google Scholar
• Kawakami A, Eguchi K, Ueki Y, Migita K, Ida H, Kurata A. Effects of lobenzarit disodium on human endothelial cells; lobenzarit disodium inhibits proliferative response, HLA-DR antigen expression, and T cell adherence toward endothelial cells. Arthritis Rheum 1991; 34: 296–303
   PubMedGoogle Scholar
• Haskard D, Cavender D, Betty P, Springer T, Ziff M. T lymphocyte adhesion to endothelial cells: mechanism demonstrated by anti-LFA-1 monoclonal antibodies. J Immunol 1986; 137: 2901–2906
   PubMed Web of Science ®Google Scholar
• Magkoba MW, Sanders ME, Ginther Luce GE., Dustin ML, Springer TA, Clark EA. ICAM-1: a ligand for LFA-1 dependent adhesion of B, T and myeloid cells. Nature 1988; 331: 86–88
   PubMedGoogle Scholar
• Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 1989; 339: 61–64
   PubMed Web of Science ®Google Scholar
• Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskij S, Hemler ME. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990; 60: 577–584
   PubMed Web of Science ®Google Scholar
• Schwartz BR, Wayner EA, Carlos TM, Ochs HD, Harlam JW. Identification of surface proteins mediating adherence of CDll/CD18-deficient lymphoblastoid cells to cultured human endothelium. J Clin Invest 1990; 85: 2019–2022
   PubMed Web of Science ®Google Scholar
• Yu CL, Haskard DO, Cavender DE, Johnson AR, Ziff M. Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol 1985; 62: 554–560
   PubMed Web of Science ®Google Scholar
• Cavender DE, Haskard DO, Joseph B, Ziff M. Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol 1986; 136: 203–207
   PubMed Web of Science ®Google Scholar
• Cavender DE, Saegusa Y, Ziff M. Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J Immunol 1987; 139: 1855–1860
   PubMed Web of Science ®Google Scholar
• Bagnasco M, Caretto A, Olive D, Pedini B, Canonica GW, Betterle C. Expression of intercellular adhesion molecule-1 (ICAM-1) on thyroid epithelial cells in Hashimoto's thyroiditis but not in Graves' disease or papillary thyroid cancer. Clin Exp Immunol 1991; 83: 309–313
   PubMed Web of Science ®Google Scholar
• Nakao H, Eguchi K, Kawakami A, Migita K, Otsubo T, Ueki Y. Phenotypic characterization of lymphocytes infiltrating synovial tissue from patients with rheumatoid arthritis: analysis of lymphocytes isolated immunofluorescent staining. J. Rheumatol 1990; 17: 142–148
   PubMed Web of Science ®Google Scholar
• Moore K, Walters MT, Jones DB, Garvey E, Harvey J, Cawley MID. An immunohistological study of CD4+ lymphocyte subsets with inflammatory lesions with special references to rheumatoid arthritis and inflammatory bowel disease. Immunology 1988; 65: 457–463
   PubMedGoogle Scholar
• Sobel RA, Hafler DA, Castro EE, Morimoto C, Weiner HL. The 2H4(CD45R) antigen is selectively decreased in multiple sclerosis lesions. J Immunol 1988; 140: 2210–2214
   PubMed Web of Science ®Google Scholar
• Sanders ME, Makgoba MW, Sharrow SO, Stephany D, Springer TA, Young HA. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD-2, and LFA-1) and three other molecules (UCHL1, CDW29, and Pgp-1) and have enhanced IFN-T production. Immunology, 2: 1401401–1411
   Google Scholar
• Shimizu Y, Shaw S, Graber N., Gopal TV, Horgan KJ, van Seventer GA. Activation independent adhesion of human memory T cells to adhesion molecules. Nature 1991; 349: 799–802
   PubMed Web of Science ®Google Scholar
• Shimizu Y, van Sev˙enter GA, Horgan KJ, Shaw S. Roles of adhesion molecules in T-cell recognition: fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation. J Immunol 1990; 144: 4579–4586
   PubMedGoogle Scholar
• van Seventer GA, Newman W, Shimizu Y, Nutman TB, Tanaka Y, Horgan KJ. Analysis of T cell stimulation by super-antigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. J Exp Med 1991; 174: 901–913
   PubMed Web of Science ®Google Scholar
• Weetman AP, Cohen S, Makgoba MW, Borysiewicz LK. Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cells. J Endocrinol 1989; 122: 185–191
   PubMed Web of Science ®Google Scholar
• Fowler PD, Tacker M, Whitley GSTJ, Meager A, Nussey SS, Johnston AP. Expression of intercellular adhesion molecule-1 (ICAM-1) on human thyroid cell lines correlated with their binding of lymphoblasts. Mol Cell Endocrinol 1990; 71: 55–61
   PubMed Web of Science ®Google Scholar
• Martin A, Huber GK, Davies TF. Induction of human thyroid cell ICAM-1 (CD54) antigen expression and ICAM-1-mediated lymphocyte binding. Endocrinology 1990; 127: 651–657
   PubMed Web of Science ®Google Scholar
• Eguchi K, Otsubo T, Kawabe Y, Ueki Y, Fukuda T, Matsunaga M. The remarkable proliferation of helper T cell subset in responses to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease. Clin Exp Immunol 1987; 70: 403–410
   PubMed Web of Science ®Google Scholar
• Otsubo T, Eguchi K, Shimomura C, Ueki Y, Tezuka H, Ishikawa N. In vitro cellular interactions among thyrocytes, T cells and monocytes from patients with Graves' disease. Acta Endocrinol 1988; 117: 282–288
   PubMedGoogle Scholar
• Eguchi K, Otsubo T, Kawabe Y, Shimomura C, Ueki Y, Nakao H. Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease. Clin Exp Immunol 1988; 72: 84–90
   PubMedGoogle Scholar
• Londei M, Lamb JR, Bottazzo GF, Feldman M. Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 1984; 312: 639–641
   PubMed Web of Science ®Google Scholar
• Londei M, Bottazzo GF, Feldman M. Human T cell clones from autoimmune glands: specific recognition of autologous thyroid cells. Science 1985; 228: 85–89
   PubMed Web of Science ®Google Scholar
• Mackenzie WA, Schwartz AE, Friedman EW, Davies TF. Intrathyroidal T cell clones from patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1987; 64: 818–824
   PubMed Web of Science ®Google Scholar
• Fisfalen ME, DeGroot LJ, Quintans J, Franklin WA, Soltani K. Microsomal antigen-reactive lymphocyte lines and clones derived from thyroid tissue of patients with Graves' disease. J Clin Endocrinol Metab 1988; 66: 776–784
   PubMed Web of Science ®Google Scholar